Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 2 Interventional

A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes

ClinicalTrials.gov ID: NCT07357740

Public ClinicalTrials.gov record NCT07357740. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 2:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study to Compare Two Presentations of CagriSema in Participants With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being done to look at how well a study medicine called CagriSema helps people with diabetes lower their blood sugar. In this study the sponsor will compare two version of CagriSema injected by two different types of injection devices. Which treatment participants get is decided by chance. CagriSema is still being tested in studies and is not yet available for doctors to prescribe. The study will last for about 38 weeks.

Study identification

NCT ID
NCT07357740
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 26, 2026
Primary completion
Aug 24, 2027
Completion
Oct 12, 2027
Last update posted
Jul 8, 2026

2026 – 2027

United States locations

U.S. sites
21
U.S. states
10
U.S. cities
19
Facility City State ZIP Site status
Arkansas Clinical Research Little Rock Arkansas 72205
Paradigm Clinical Research San Diego California 92108
Encompass Clinical Research_Spring Valley Spring Valley California 91978
Diablo Clinical Research, Inc. Walnut Creek California 94598
Future Medical Research Longwood Florida 32750
New Horizon Research Center Miami Florida 33165
Clinical Site Partners Kendall Flourish Research Miami Florida 33186
West Orange Endocrinology Ocoee Florida 34761
Center for Diab,Obes & Metab Pembroke Pines Florida 33024
American Research Centers of Florida Pembroke Pines Florida 33027
Hope Clin Res & Wellness Conyers Georgia 30094
Elevate Clinical Research Gurnee Illinois 60031
Accellacare of Duly Oak Lawn Oak Lawn Illinois 60453
KDCILM, LLC & Accellacare US, Inc. Wilmington North Carolina 28401
Advanced Medical Research - Maumee Maumee Ohio 43537
Clinical Res Collaborative Cumberland Rhode Island 02864
Clinical Research Associates Nashville Tennessee 37203
The Endocrine Center Houston Texas 77079
Radiance Clinical Research Lampasas Texas 76550
Quality Research Inc San Antonio Texas 78209
Medrasa Clinical Research Sherman Texas 75092

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07357740, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 8, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07357740 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →